Harvest Fund Management Co., Ltd - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 425 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.2%.

Quarter-by-quarter ownership
Harvest Fund Management Co., Ltd ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$57
-99.9%
1,002
-49.2%
0.02%
-37.5%
Q2 2022$87,000
+357.9%
1,973
+317.1%
0.02%
+500.0%
Q3 2021$19,000
-50.0%
473
-43.6%
0.00%0.0%
Q2 2021$38,000
-44.9%
839
-50.0%
0.00%
-42.9%
Q1 2021$69,000
-2.8%
1,6770.0%0.01%
+16.7%
Q4 2020$71,000
+61.4%
1,6770.0%0.01%
+50.0%
Q3 2020$44,0001,6770.00%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
SNYDER CAPITAL MANAGEMENT L P 4,324,232$165,185,6623.73%
Steamboat Capital Partners, LLC 196,898$7,521,5042.79%
2Xideas AG 600,799$22,950,5222.54%
BERNZOTT CAPITAL ADVISORS 171,808$6,563,0662.26%
Redwood Investments, LLC 328,459$12,547,1341.70%
Mesirow Institutional Investment Management, Inc. 380,415$14,531,8531.47%
Granite Investment Partners, LLC 856,253$32,708,8651.37%
Penn Capital Management Company, LLC 324,707$12,453,2111.28%
EFG Asset Management (North America) Corp. 137,739$5,262,3191.25%
First Light Asset Management, LLC 313,536$11,977,0751.14%
View complete list of HALOZYME THERAPEUTICS INC shareholders